THE NEXT GENERATION OF VACCINES

unimportant decoration Nano-scale droplet illustration

Vaccine Pipeline

unimportant decoration

NanoBio’s intranasal vaccine technology has demonstrated safety and immunogenicity in Phase 1 clinical studies for seasonal influenza. Several other programs have advanced through successful challenge studies in primary animal models. Choose a pathogen and click for details on our research results and partnering information.

Table showing NanoBio's research pipeline and vaccine statuses